Mission
To create a world where medical services can be accessed with technology anywhere, anytime
Vision
Through the power of technology, we strive to support all healthcare professionals and to create a world where better medical services can be accessed.
Value
- Prioritize the customer.
- Businesses don't exist without customers and our first priority is to solve their problems and ensure their satisfaction.
- Move forward quickly without compromising quality.
- Quality is especially important in healthcare where human lives are involved. We ensure the quality of our work. For startups, speed is just as important as quality. It's worthwhile how quickly you accomplish the task.
- Opt for decisions that will substantially propel the business forward.
- If there are several ways or options, choose the one that will move the business forward the most.
- Think positively and move forward.
- When striving to achieve something new, there is a big possibility to face numerous obstacles. It is important to overcome them with a positive mindset and continue moving forward.
- Respect individuality and the various styles of work and thinking.
- Diversity brings new perspectives and values, enabling the sustainable growth of the company.
- Play as a team.
- We are a team brought together to accomplish a common mission, and team play is very important.
- Excel in professionalism as individuals.
- We all should take pride and responsibility in our work.
- Take thoughtful action proactively.
- Instead of being passive, we should thoroughly think for ourselves and take proactive steps towards achieving their goals.
- Grow both as a company and as individuals.
- Through our business, we will not only grow the company significantly, but also grow as individuals.
Board Members
-
CEO
Osamu Iizuka
-
Board of Director
Masayuki Tsuneki
Worked at Niigata University, Yale University, and National Cancer Center as a pathology researcher, a pathologist, and an academic teacher. Throughout his career, Masayuki had been working on research on molecular pathology, particularly related to carcinogenesis. He is eager to create a new technology that can provide an objective diagnosis in the field of clinical pathology. With his professional knowledge of human pathology, Masayuki has strength in international academic researches.
-
Outside Director
Katsumasa Niki
As the head of the investment division of the SoftBank Group Corp., until 2016, he was in charge of investment projects at various stages both in Japan and overseas. He has been involved in major M&A such as Vodafone K.K. and Sprint, as well as investments in foreign technology companies and start-ups, and serves on the board of directors at both international and domestic companies. He has also served as an investment committee member at several domestic and international VCs. He currently supports start-ups as an AI-focused incubator and a president and CEO of VC DEEPCORE.
-
Outside Director
Shigeo Nakano
After graduating from Keio University School of Medicine and Graduate School of the same university, he worked at University of Occupational and Environmental Health and the Pathology Department of Saga Medical University. After that, he was engaged in research on skin pathology diagnosis at the Dermatopathology Laboratory of Thomas Jefferson University in the United States. After returning to Japan, he established a medical institution specializing in pathological diagnosis, and is currently engaged in hospital management and pathological diagnosis as the chief of the Kanto Regional Headquarters of the Kamachi Group and the general manager of pathological diagnosis department. His specialty is dermatopathology.
Company
| Company name | Medmain Inc. |
|---|---|
| Office |
[ Fukuoka ] 104,2-4-5 Akasaka Chuo-ku Fukuoka, 810-0042 Japan [ Tokyo ] Aoyama Building 2F, 2-10-11 Minami Aoyama, Minato-ku,Tokyo,Japan [ US ] 212 Homer Ave, Palo Alto, CA 94301 USA (Medmain USA Inc.) |
| CEO | Osamu Iizuka |
| Date founded | Jan 11th 2018 |
| Capital | JPY 1,190,000,000 (Capital reserve included) |
| Main business activities | Planning, development, operation and sales of medical software products, cloud service |
| Certification |
 ISMS Certification Certification Standards：ISO/IEC 27001:2022 and JIS Q 27001:2023 Registration Number：JP24/00000322 Certification Scope：Planning, development, operation and sales of medical software products, cloud service First Registration Date：November 4, 2024 Certification Body：SGS Japan Inc. |
An undergraduate of the Department of Medicine, Kyushu Univ. School of Medicine. Osamu has many experiences of developing software in Machine Learning, Deep Learning & Web. After working as a web-engineer in a startup, and winning first place at a pitch competition in Silicon Valley, he founded Medmain with a few members from Kyushu University.